Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system.
ICAgen, a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.
Second Genome is a biotechnology company pioneering the field of microbiome research to develop improved ways for treating chronic disease and illness.
Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
G-CON’s flexible, modular production units, PODs, are a unique, disruptive technology, which has not been seen within the industry since single-use bags entered the market.
RefleXion Medical is developing the biology-guided radiotherapy system for cancer treatment.
Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease.
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Lodo Therapeutics is a drug discovery and development company.
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Palleon Pharmaceuticals is a biotechnology company focused on developing Glycoimmune Checkpoint inhibitors to treat cancer.